Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies

Nature Chemistry

Volumn 8, Issue 4, 2016, Pages 338-346

  Shivatare, Sachin S ^a,b,c,d   Chang, Shih Huang ^a,c   Tsai, Tsung I ^e   Tseng, Susan Yu ^a   Shivatare, Vidya S ^a   Lin, Yih Shyan ^d   Cheng, Yang Yu ^a   Ren, Chien Tai ^a   Lee, Chang Chun David ^a   Pawar, Sujeet ^a,b   Tsai, Charng Sheng ^d   Shih, Hao Wei ^d   Zeng, Yi Fang ^d   Liang, Chi Hui ^a,e   Kwong, Peter D ^f   Burton, Dennis R ^e   Wu, Chung Yi ^a   Wong, Chi Huey ^a,e  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHO PHARMA INC   (Taiwan)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIGAND; NEUTRALIZING ANTIBODY; POLYSACCHARIDE;

CHEMISTRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; SYNTHESIS;

AIDS VACCINES; ANTIBODIES, NEUTRALIZING; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LIGANDS; POLYSACCHARIDES;

EID: 84961627827     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.2463     Document Type: Article

References (59)

1. Barouch, D. H. Challenges in the development of an HIV-1 vaccine. Nature 455, 613-619 (2008).
2. Gaschen, B. et al. AIDS-diversity considerations in HIV-1 vaccine selection. Science 296, 2354-2360 (2002).
3. Astronomo, R. D. & Burton, D. R. Carbohydrate vaccines: developing sweet solutions to sticky situations? Nature Rev. Drug. Discov. 9, 308-324 (2010).
4. Craigo, J. K. & Montelaro, R. C. Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity. Viruses 5, 2963-2976 (2013).
5. Scanlan, C. N., Offer, J., Zitzmann, N. & Dwek, R. A. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 446, 1038-1045 (2007).
6. Kwong, P. D., Mascola, J. R. & Nabel, G. J. Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1. Cold Spring Harb. Perspect. Med. 1, a007278 (2011).
7. Burton, D. R. & Mascola, J. R. Antibody responses to envelope glycoproteins in HIV-1 infection. Nature Immunol. 16, 571-576 (2015).
8. Pritchard, L. K., Harvey, D. J., Bonomelli, C., Crispin, M. & Doores, K. J. Celland protein-directed glycosylation of native cleaved HIV-1 envelope. J. Virol. 89, 8932-8944 (2015).
9. Pritchard, L. K. et al. Structural constraints determine the glycosylation of HIV-1 envelope trimers. Cell Rep. 11, 1604-1613 (2015).
10. Doores, K. J. et al. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc. Natl Acad. Sci. USA 107, 13800-13805 (2010).
11. Pabst, M., Chang, M., Stadlmann, J. & Altmann, F. Glycan profiles of the 27 Nglycosylation sites of the HIV envelope protein CN54gp140. Biol. Chem. 393, 719-730 (2012).
12. Go, E. P. et al. Comparative analysis of the glycosylation profiles of membraneanchored HIV-1 envelope glycoprotein trimers and soluble gp140. J. Virol. 89, 8245-8257 (2015).
13. Wang, W. et al. A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization. Retrovirology 10, 14 (2014).
14. Calarese, D. A. et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300, 2065-2071 (2003).
15. Wang, L. X. Carbohydrate-based vaccines against HIV/AIDS. ACS Symp. Ser. 932, 133-160 (2006).
16. Joyce, J. G. et al. An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions. Proc. Natl Acad. Sci. USA 105, 15684-15689 (2008).
17. Wang, L. X. Synthetic carbohydrate antigens for HIV vaccine design. Curr. Opin. Chem. Biol. 17, 997-1005 (2013).
18. Horiya, S., MacPherson, I. S. & Krauss, I. J. Recent strategies targeting HIV glycans in vaccine design. Nature Chem. Biol. 10, 990-999 (2014).
19. Fernandez-Tejada, A., Haynes, B. F. & Danishefsky, S. J. Designing synthetic vaccines for HIV. Exp. Rev. Vaccines 14, 815-831 (2015).
20. Walker, L. M. et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466-470 (2011).
21. Sok, D., Moldt, B. & Burton, D. R. Snap Shot: broadly neutralizing antibodies. Cell 155, 728 (2013).
22. Garces, F. et al. Structural evolution of glycan recognition by a family of potent HIV antibodies. Cell 159, 69-79 (2014).
23. Wu, X. et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856-861 (2010).
24. Pancera, M. et al. Crystal structure of PG16 and chimeric dissection with somatically related PG9 structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1. J. Virol. 84, 8098-8110 (2010).
25. Doores, K. J. & Burton, D. R. Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16. J. Virol. 84, 10510-10521 (2010).
26. McLellan, J. S. et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480, 336-343 (2011).
27. Pejchal, R. et al. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334, 1097-1103 (2011).
28. Mouquet, H. et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc. Natl Acad. Sci. USA 109, E3268-E3277 (2012).
29. Falkowska, E. et al. Broadly neutralizing HIV antibodies define a glycandependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. Immunity 40, 657-668 (2014).
30. Pancera, M. et al. Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16. Nature Struct. Mol. Biol. 20, 804-813 (2013).
31. Amin, M. N. et al. Synthetic glycopeptides reveal the glycan specificity of HIVneutralizing antibodies. Nature Chem. Biol. 9, 521-526 (2013).
32. Murphy, C. I. et al. Enhanced expression, secretion, and large-scale purification of recombinant HIV-1 gp120 in insect cell using the baculovirus egt and p67 signal peptides. Protein Expr. Purif. 4, 349-357 (1993).
33. Kong, L. et al. Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity. J. Mol. Biol. 403, 131-147 (2010).
34. Go, E. P. et al. Characterization of glycosylation profiles of HIV-1 transmitted/founder envelopes by mass spectrometry. J. Virol. 85, 8270-8284 (2011).
35. Eggink, D. et al. Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function. Virology 401, 236-247 (2010).
36. Zhu, X., Borchers, C., Bienstock, R. J. & Tomer, K. B. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39, 11194-11204 (2000).
37. Raska, M. et al. Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. J. Biol. Chem. 285, 20860-20869 (2010).
38. De Paz, J. L., Horlacher, T. & Seeberger, P. H. Oligosaccharide microarrays to map interactions of carbohydrates in biological systems. Methods Enzymol. 415, 269-292 (2006).
39. Oyelaran, O. & Gildersleeve, J. C. Glycan arrays: recent advances and future challenges. Curr. Opin. Chem. Biol. 13, 406-413 (2009).
40. Rillahan, C. D. & Paulson, J. C. Glycan microarrays for decoding the glycome. Annu. Rev. Biochem. 80, 797-823 (2011).
41. Blixt, O. et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl Acad. Sci. USA 101, 17033-17038 (2004).
42. Fukui, S., Feizi, T., Galustian, C., Lawson, A. M. & Chai, W. Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nature Biotechnol. 20, 1011-1017 (2002).
43. Wang, D., Liu, S., Trummer, B. J., Deng, C. & Wang, A. Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells. Nature Biotechnol. 20, 275-281 (2002).
44. Fazio, F., Bryan, M. C., Blixt, O., Paulson, J. C. & Wong, C.-H. Synthesis of sugar arrays in microtiter plate. J. Am. Chem. Soc. 124, 14397-14402 (2002).
45. Paulson, J. C., Blixt, O. & Collins, B. E. Sweet spots in functional glycomics. Nature Chem. Biol. 2, 238-248 (2006).
46. Scurr, D. J. et al. Surface characterization of carbohydrate microarrays. Langmuir 26, 17143-17155 (2010).
47. Chang, S. H. et al. Glycan array on aluminum oxide-coated glass slides through phosphonate chemistry. J. Am. Chem. Soc. 132, 13371-13380 (2010).
48. Tseng, S. Y. et al. Glycan arrays on aluminum-coated glass slides. Chem. Asian J. 3, 1395-1405 (2008).
49. Wang, Z. et al. A general strategy for the chemoenzymatic synthesis of asymmetrically branched N-glycans. Science 341, 379-383 (2013).
50. Shivatare, S. S. et al. Efficient convergent synthesis of bi-, tri-, and tetraantennary complex type N-glycans and their HIV-1 antigenicity. J. Am. Chem. Soc. 135, 15382-15391 (2013).
51. Li, L. et al. Efficient chemoenzymatic synthesis of an N-glycan isomer library. Chem. Sci. 6, 5652-5661 (2015).
52. Takakura, Y., Tsukamoto, H. & Yamamoto, T. Molecular cloning, expression and properties of an α/β-galactoside α2,3-sialyltransferase from Vibrio sp. JTFAJ-16. J. Biochem. 142, 403-412 (2007).
53. Tsukamoto, H., Takakura, Y., Mine, T. & Yamamoto, T. Photobacterium sp. JTISH-224 produces two sialyltransferases, α-/β-galactoside α2,3-sialyltransferase and β-galactoside α2,6-sialyltransferase. J. Biochem. 143, 187-197 (2008).
54. Toshima, K. Glycosyl fluorides in glycosidations. Carbohydr. Res. 327, 15-26 (2000).
55. Rabbani, S., Schwardt, O. & Ernst, B. Glycosyltransferases: an efficient tool for the enzymatic synthesis of oligosaccharides and derivatives as well as mimetics thereof. Chimia 60, 23-27 (2006).
56. Muthana, S., Yu, H., Huang, S. & Chen, X. Chemoenzymatic synthesis of sizedefined polysaccharides by sialyltransferase-catalyzed block transfer of oligosaccharides. J. Am. Chem. Soc. 129, 11918-11919 (2007).
57. Lau, K. et al. Highly efficient chemoenzymatic synthesis of β1-4-linked galactosides with promiscuous bacterial β1-4-galactosyltransferases. Chem. Commun. 46, 6066-6068 (2010).
58. Soriano del Amo, D. et al. Chemoenzymatic synthesis of the sialyl Lewis X glycan and its derivatives. Carbohydr. Res. 345, 1107-1113 (2010).
59. Liang, P. H., Wang, S. K. & Wong, C.-H. Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants. J. Am. Chem. Soc. 129, 11177-11184 (2007).